Clinical Trials on NSAIDs Hypersensitivity in New Zealand

Total 1341 results

GlaxoSmithKline

Completed

Spacer Comparison In Adult Asthmatics

Asthma

New Zealand
GlaxoSmithKline

Completed

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

Asthma

New Zealand
GlaxoSmithKline

Completed

Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

Asthma

New Zealand
GlaxoSmithKline

Completed

This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge

Asthma

New Zealand
GlaxoSmithKline

Completed

The Effect Of AVANDIA On The Late Asthmatic Response

Asthma

New Zealand
University of Otago

Completed

Does Improving Insulation and Heating Improve Health?

Asthma

New Zealand
GlaxoSmithKline

Completed

Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate

Asthma

New Zealand
GlaxoSmithKline

Completed

A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

Asthma

New Zealand
Resistentia Pharmaceuticals AB

Completed

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

Allergy

New Zealand
Tavotek Biotherapeutics

Recruiting

A Study of TAVO101 in Atopic Dermatitis Patients

Atopic Dermatitis

New Zealand
GlaxoSmithKline

Completed

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Asthma

United Kingdom, New Zealand
AstraZeneca

Completed

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Asthma

New Zealand, United Kingdom
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
GlaxoSmithKline

Completed

Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing

Asthma

New Zealand, South Africa
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

Asthma

United Kingdom, Germany, New Zealand
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

Asthma

Sweden, Australia, New Zealand
Ribon Therapeutics, Inc.

Recruiting

SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects

Atopic Dermatitis

Australia, New Zealand
Naestved Hospital

Recruiting

Implementation of Evidence-based Breathing Retraining for Patients With Asthma in Region Zealand (EmBRAiZ)

Asthma

Denmark
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
Equillium
Biocon Limited; Equillium AUS Pty Ltd

Completed

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (EQUIP)

Asthma

New Zealand, Australia
Intellia Therapeutics

Not yet recruiting

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Hereditary Angioedema

France, New Zealand, United Kingdom
Mundipharma Research Limited

Completed

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

Asthma

United Kingdom, Sweden, Australia, New Zealand, Slovakia
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Regeneron Pharmaceuticals
Sanofi

Completed

Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

Germany, New Zealand, Australia
Allergan

Completed

Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Atopic Conjunctivitis

Canada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
Intellia Therapeutics

Active, not recruiting

NTLA-2002 in Adults With Hereditary Angioedema (HAE) (NTLA-2002)

Hereditary Angioedema

France, New Zealand, Germany, United Kingdom, Netherlands, Australia
John Hunter Children's Hospital
Thrasher Research Fund; Aerocrine AB; University of Newcastle, Australia; Hunter... and other collaborators

Completed

PEAnut Anaphylaxis Predictors (PEAAP)

Peanut Hypersensitivity | Anaphylaxis

Australia
National Institute of Allergy and Infectious Diseases...

Completed

An Interventional Study of Milk Allergy

Milk Hypersensitivity | Food Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Asthma and Allergic Diseases Cooperative Research Centers

Completed

Study of Milk Allergy and Tolerance in Children

Milk Hypersensitivity | Food Hypersensitivity

United States
Scott Sicherer
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy (CAFETERIA)

Peanut Allergy | Food Allergy

United States
Weill Medical College of Cornell University

Completed

Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy

Peanut Allergy

United States
Allertein Therapeutics, LLC
Consortium of Food Allergy Research

Completed

Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Terminated

Impact of Vaccination on Th2 Immunity in Infancy

Food Hypersensitivity

United States
Intrommune Therapeutics

Completed

OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut

Peanut Allergy

United States
Johns Hopkins University
Icahn School of Medicine at Mount Sinai

Terminated

The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy

Peanut Allergy

United States
Icahn School of Medicine at Mount Sinai

Recruiting

JAK Inhibition in Food Allergy

Food Allergy

United States
Icahn School of Medicine at Mount Sinai
Fordham University

Completed

Self-injection and Self-management

Food Allergy

United States
Icahn School of Medicine at Mount Sinai
Société des Produits Nestlé (SPN)

Completed

Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients

Food Allergy

United States
University of Rochester
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)

Egg Allergy | Food Allergy Peanut | Food Allergy in Infants | Allergy and Immunology | Peanut and Nut Allergy

United States
Northwell Health
Masimo Corporation

Completed

Pleth Variability and Asthma Severity in Children

Status Asthmaticus

United States
Hugh A Sampson, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

Milk Allergy

United States
Icahn School of Medicine at Mount Sinai

Completed

Anxiety About Casual Exposure to Food Allergens (TOUCH)

Food Allergy

United States
Xiu-Min Li

Unknown

E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy

Food Allergy

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

An Observational Study of Childhood Food Allergy

Milk Hypersensitivity | Egg Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial

Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Peanut Oral Immunotherapy in Children (IMPACT)

Peanut Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
Li, Xiu-Min, M.D.
National Center for Complementary and Integrative Health (NCCIH)

Unknown

Therapeutic Effect of Chinese Herbal Medicine on Food Allergy (FAHF-2)

Food Allergy

United States
Hugh A Sampson, MD

Completed

Oral Immunotherapy for Wheat Allergy (Wheat OIT)

Wheat Allergy

United States
Hoosier Cancer Research Network
University of Sydney; Bionomics Limited; Australia New Zealand Gynaecological...

Withdrawn

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Ovarian Cancer

United States, Australia, New Zealand

Clinical Trials on NSAIDs Hypersensitivity in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations